Federation Des Caisses Desjardins Du Quebec Atai Life Sciences N.V. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 150 shares of ATAI stock, worth $184. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 150
-0.0%
Holding current value
$184
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ATAI
# of Institutions
87Shares Held
12.4MCall Options Held
77.8KPut Options Held
50.3K-
Morgan Stanley New York, NY3.04MShares$3.74 Million0.0% of portfolio
-
Walleye Capital LLC Plymouth, MN2.26MShares$2.79 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$1.61 Million0.0% of portfolio
-
Brown University719KShares$883,7550.36% of portfolio
-
Round Table Services, LLC704KShares$865,9200.46% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $204M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...